$56.85
-1.69 (-2.89%)
Performance
1D
—
1W
—
1M
—
3M
+19.76%
6M
+81.51%
1Y
+72.53%
YTD
+75.52%
Open$58.69
Previous Close$58.54
Day High$59.00
Day Low$56.00
52W High$66.06
52W Low$23.30
Volume—
Avg Volume1.54M
Market Cap3.54B
P/E Ratio—
EPS$-1.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$39.72
Above
SMA 200
$33.17
Above
RSI (14)
70
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+25.9% upside
Current
$56.85
$56.85
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 392.08M | 319.41M | 1.46B |
| Net Income | -80,871,757 | -59,294,974 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -66,076,093 | -51,138,320 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |